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Abstract. Quercetin (3,3’4’,5,7-pentahydroxyflavone) has been reported to show 
anti-inflammatory activity. However, its low oral bioavailability limits the 
application of quercetin in therapy. Ester derivatives of quercetin have been 
reported to have higher bioavailability than quercetin. This research aimed to 
study the anti-inflammatory activities and gastric ulcer-inducing properties of 
tetraacetylquercetinas well as tetrapivaloylquercetin. Synthesis of tetra-acyl 
derivatives of quercetin was conducted using acetic anhydride or pivaloyl 
chloride in the presence of pyridine and the structure was confirmed by 1H-NMR 
and 13C-NMR spectroscopy as well as elemental analysis. At a dose of 20 mg/kg 
bw, oral administration of quercetin only showed 20% inhibition activity on 
carragenan induced rat paw edema, while tetraacetyl and tetrapivaloyl 
derivatives at equimolar dose showed 11-33% and 5-15% inhibition activity 
respectively. Contrary to the gastric ulcer healing-promoting action of quercetin, 
tetraacetylquercetin caused mild gastric ulcers. However, no gastric ulcer was 
observed after administration of tetrapivaloylquercetin. It was concluded that 
acylation enhances the anti-inflammatory activity of quercetin but causes mild 
gastric ulcers in the case of tetraacetylation. 
Keywords: anti-inflammatory activity; gastric ulcer-inducing property; 
tetraacetylquercetin; tetrapivaloylquercetin; quercetin. 
1 Introduction 
Flavonols are major dietary flavonoid and are particularly abundant in fruits and 
vegetables. It has been reported that flavonoids posses a number of biologic 
effects such as antiallergic, anti-inflammatory, antiviral, anti-proliferative and 
anticarcinogenic activities. Quercetin (3,3’,4’,5,7-pentahydroxyflavone, 
compound 1) is the main flavonol in our diet. Quercetin acts as anti-
inflammatory agent via several target pathways, i.e. modulation of cellular 
activities of inflammation-related cells, modulation of arachidonic acid-related 
enzymes, modulation of the production of other proinflammatory molecules, as 
well as modulation of proinflammatory gene expression [1]. Quercetin inhibits 
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carrageenan-induced inflammation in rats and suppresses the contents of 
prostaglandin E2 (PGE2), tumor necrosis factor-α (TNF-α) and the mRNA for 
cyclooxygenase [2]. Quercetin blocks both the cyclooxygenase (COX) and 
lipooxygenase (LOX) pathways at relatively high concentrations, while at lower 
concentrations the LOX pathway is the primary target of anti-inflammatory 
activity. When intraperitoneally administered, quercetin decreases the 
production of edema in the acute phase after carrageenan injection, but has no 
significant action on the chronic phase [3,4]. Quercetin has also been reported to 
promote antioxidant enzyme activity, prevent free radical attacks as well as 
enhance endogenous antioxidant molecules [1]. In addition, quercetin possesses 
gastric protective and gastric ulcer healing-promoting action [5], so quercetin 
was chosen as lead compound for the development of anti-inflammatory agents 
with low-risk of gastrointestinal toxicity. 
However, there are conflicting reports of its in vivo and in vitro activity. When 
orally administered, quercetin shows weak anti-inflammatory activity, as 
opposed to the strong COX inhibition in vitro. This is due to the poor 
bioavailability of quercetin, which is practically insoluble in water or oil [6]. In 
addition, after oral administration, quercetin is rapidly glucuronated, sulfated 
and methylated. To overcome these limitations, introduction of lipophilic 
substituent may increase its permeability into the cell or increase the affinity for 
the plasma membrane and thus improve its biological activity. Esters are the 
most commonly added moiety to increase lipophilicity and mask hydrogen-
bonding groups of the active compound [7]. Biasutto, et al. [8] reported that 
esterification of quercetin can be a useful method to increase the systemic 
concentration of quercetin. From their transepithelial absorption study using 
Caco-2 cells, it was concluded that acyl moieties protect the hydroxyl group of 
quercetin from the metabolism reaction. 
In this study tetraacetylquercetin (TAQ) and tetrapivaloylquercetin (TPQ) were 
synthesized and their anti-inflammatory activity against carrageenan induced rat 
paw edema was examined as well as gastrointestinal safety by ulcer index 
determination. 
2 Materials and Methods 
2.1 Materials 
Quercetin and λ-carrageenan were purchased from Sigma-Aldrich. Other 
chemicals, i.e. acetic anhydride, pyridine, ethanol, pivaloyl chloride, methylene 
chloride, hydrochloride acid, acetone, and MgSO4, were purchased from 
Merck. The sodium diclofenac and the sodium CMC were pharmaceutical 
grade. 
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Healthy male Wistar albino rats, weighing 150-200 g, 12-16 weeks old were 
utilized in this study. They were housed in cages under standard laboratory 
conditions (12 hours of light period, 27±3°C). The animals were given standard 
rat pellets and tap water ad libitum. The animals were obtained from the Animal 
Laboratory, School of Pharmacy, Institut Teknologi Bandung, Indonesia and 
were maintained in colony cages at 25-30 °C and fed standard animal feed. All 
animals were acclimatized for a week before use. The Institutional Animal 
Ethics committee has approved the protocol adopted for the experimentation of 
animals. The animals were randomly grouped into 5 groups, each group 
consisting of 6 animals. The test compounds (quercetin 20 mg/kg, TPQ 42.2 
mg/kg, TAQ 31.1 mg/kg, sodium diclofenac 5 mg/kg as well as vehicle control) 
were orally administered 30 minutes prior to carrageenan induction). The edema 
volumes were measured by plethysmograph before induction and every hour 
after induction.  
2.2 Methods 
Thin layer chromatography was performed using precoated silica gel plates 
(Merck 60 F254) and detection of the components was conducted by 254 nm 
UV light. Melting points were measured with a melting point apparatus and 
were uncorrected. 1H-NMR and 13C-NMR were made on a JEOL 250 MHz 
using tetrametylsilane (TMS) as the internal standard. Chemical shifts (δ) are 
expressed in ppm downfield from TMS. Elemental analyses were carried out on 
a Heraeus elemental analyzer; the results are within ± 0.4% of the theoretical 
values. Column chromatography was performed on 70-230 mesh silica gel from 
Merck. Figure 1 outlines the synthesis scheme of tetra-ester quercetin. 
3,3’,4’,7-tetraacetylquercetin (2) was synthesized using the standard procedure 
reported in[9]. In a dry flask, anhydrous quercetin (1.51 g, 5 mmol), acetic 
anhydride (15 ml, 0.15 mol) and 5 drops of pyridine were reacted at room 
temperature, until no yellow appearance of quercetin was observed. After 10 
minutes the residue was washed with cold water and recrystallized in absolute 
ethanol. This yielded 1.55 g (65.9 %) of white crystal with a melting point of 
69.0-69.5°C. Analysis with 1H NMR (250 MHz, DMSOd6) showed the 
following spectra data: δ = 2.07-2.35 (m, 12H, CH3-C=O), 6.74 (d, J=2 Hz, 1H, 
H6), 7.13 (d, J=2 Hz, 1H, H8), 7.53 (dd, J=2.7 Hz, 6.45 Hz, 1H, H6’), 7.85-7.89 
(m, 2H, Ar.). Analysis with13C NMR (250 MHz, DMSOd6) showed the 
following spectra data: δ = 20.81, 20.85, 21.05 (CH3), 102.56 (C8), 106.11 (C6), 
108.59 (C9), 124.35 (C2’), 125.03 (C5’), 127.3 (C6’), 127.39 (C1’), 132.03 (C3), 
142.66 (C3’), 145.14 (C4’), 155.59 (C2), 156.06 (C10), 156.78 (C7), 160.76 (C5), 
168.22, 168.44, 168.64, 168.79 (C=O), 176.07(C4). Elemental analysis revealed 
the following contents: C: 58.76%, H: 3.84% (Calcd. C: 58.73%, H: 3.86%). 
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3,3’,4’,7-tetrapivaloylquercetin (3) was analogously synthesized according to 
the procedure reported by Mattarei, et al. [10]. Pivaloyl chloride (12.06 ml, 0.1 
mol) was added dropwise and under continuous stirring to a mixture of 
quercetin (1.55 g, 5 mmol) and anhydrous pyridine (4.25 ml, 50 mmol) that was 
previously cooled in a dry ice bath. A white precipitate (pyridinium chloride) 
formed immediately. The mixture was subsequently allowed to warm to room 
temperature and was stirred overnight. CH2Cl2 (50 ml) was then added and the 
organic layer was washed with cold 0.5N HCl (3x50 ml) and cold H2O (2 x 30 
ml). The organic phase was then dried and filtered over anhydrous MgSO4. The 
solvent was evaporated under reduced pressure and the residue was purified by 
flash chromatography using CH2Cl2/chloroform/acetone (14:5:1) as mobile 
phase. This yielded 1.55 g (48.5%) of yellow crystal with a melting point of 
74.0-75.0 °C. Analysis with 1H NMR (250 MHz, CDCl3) showed the following 
spectra data: δ = 1.27-1.38 (CH3), 6.79 (d, J=2 Hz, 1H, H6), 7.28 (d, J=4.1 Hz, 
1H, H5’), 7.30 (d, J=2.3 Hz, 1H, H8), 7.62 (d, J=2.1, 1H, H2’), 7.71 (dd, 
J=2.1Hz, 5 Hz, 1H, H6’). Analysis with 13C NMR (250 MHz, CDCl3) showed 
the following spectra data: δ = 21.03-22.67 (12C, CH3), 42.29, 42.54, 42.66, 
42.78 (>C<), 108.44 (C8), 112.41 (C6), 113.95 (C9), 122.18 (C2’), 122.50 (C5’), 
125.14 (C6’), 126.50 (C1’), 132.14 (C3), 142.14 (C3’), 143.06 (C4’), 149.83 (C2), 
152.56 (C10), 154.19 (C7), 158.12 (C5), 168.22 (C4), 170.11, 170.55, 170.71, 
170.82 (C=O). Elemental analysis revealed the following contents: C: 65.72%, 
H: 6.55% (Calcd. C: 65.82%, H: 6.63%). 
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Figure 1 Scheme of 3,3’,4’,7-tetraacetylquercetin and 3,3’,4’,7-tetrapivaloyl 
quercetin synthesis. 
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The synthesized compounds were evaluated for their anti-inflammatory activity 
and ulcerogenic index in Wistar rats using the carragenan-induced rat paw 
edema method [11]. Test compounds and standard drugs were orally 
administered as a suspension (with 1% carboxymethyl cellulose as a vehicle). 
The rats were daily treated with a test compound at an equivalent dose of 20 
mg/kg bw of quercetin for 3 days. The control group rats were treated with an 
equal volume of the vehicle (0.5% carboxy methyl cellulose). The animals were 
sacrificed 4 h after the treatment. Their stomachs were observed for ulcers and 
scored as (0 = normal colored stomach, 0.5 = red coloration, 1 = spot ulcers, 1.5 
hemorrhagic streaks, 2 = ulcers > 3 but < 5, 3 = ulcer > 5) [12]. 
The results were expressed as mean ± SEM, while statistical significance was 
calculated by applying one way ANOVA. P < 0.05 was considered significant. 
3 Results and Discussion 
3.1 Anti-Inflammatory Activity 
For clarity the percentage of edema inhibiton of the test compounds is listed in 
Figure 2. Inhibition activity after oral administration of 20 mg/kg of quercetin 
was only below 10%. At equimolar dose of quercetin, inhibiton activity of TPQ 
(42.2 mg/kg) and TAQ (31.1 mg/kg) was 5-15% and 11-33% respectively. 
Sodium diclofenac (5 mg/kg) showed the highest inhibition activity. Table 1 
features the percentage of edema after induction of carrageenan. 
 
Figure 2 Edema inhibition activity of test compounds. 
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Table 1 Increase of Paw Edema after induction of carrageenan. 
Group Increase of Paw Edema (%) 1 h 2 h 3 h 4 h 5 h 6 h 
Control 
Quercetin 20 mg/kg 
TPQ 42.2 mg/kg 
TAQ 31.1 mg/kg 
Diclofenac 5 mg/kg 
28.82±2.48 
26.02±2.82 
24.21±1.65a,b 
20.58±2.78a,b 
14.70±1.01a,b 
57.80±2.96 
55.45±2.49 
51.69±2.36a,b 
38.92±3.04a,b 
23.32±2.15a,b 
89.21±4.46 
83.08±3.50a 
77.03±3.46a,b 
69.50±3.55a,b 
45.23±2.79a,b 
109.77±3.64 
101.54±4.51a 
99.56±3.16a 
93.83±3.12a,b 
50.88±2.49a,b 
112.89±2.66 
100.08±3.14 
96.77±2.79a 
93.83±3.31a,b 
58.97±3.07a,b 
114.78±3.45 
108.19±2.70a 
105.77±3.04a 
102.08±3.57a,b 
76.43±2.76a,b 
a: P < 0.05 compared to control, b: P < 0.05 compared to quercetin. 
3.2 Gastric Ulcer-Inducing Property 
Oral administration of quercetin (20 mg/kg, p.o., 3 days) did not induce gastric 
ulcers in the treated mice as well as in the control group, which received vehicle 
only (ulcer index of 0.0±0.00). Tetrapivaloylquercetin caused only minor 
damage on gastric epithelium with an ulcer index of 0.3±0.26. However, 
tetraacetylquercetin showed more severe ulcerogenic damage with an ulcer 
index of 0.9±0.20. Gastric ulcer properties of the test compounds are shown on 
Figure 3. Diclofenac caused extensive damage on the gastric epithelium with an 
ulcer index of 2.3±0.52 (Table 2).  
 
 
Figure 3 Gastric ulcer-inducing properties  of  test  compounds,  (a) control,  
(b) quercetin 20 mg/kgbw,  (c)  TAQ 31.1  mg/kgbw,  (d) TPQ 42.4 mg/kgbw, 
(e) diclofenac 5 mg/kg. Black arrows indicate ulcers. 
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Table 2 Ulcer index after 3 days of treatment with test compounds. 
Treatment Ulcer index 
Control 
Quercetin (20 mg/kgbw) 
Tetraacetylquercetin(31.1 mg/kgbw)  
Tetrapivaloylquercetin(42.2 mg/kgbw) 
Sodium diclofenac (5 mg/kgbw) 
0.0±0.00 
0.0±0.00 
0.9±0.20* 
0.3±0.26* 
2.3±0.52* 
*P < 0.05 compared to control. 
4 Discussion 
Pharmacological activities of acyl derivative flavonoids have been explored 
intensively, mainly because acylation is a simple way to improve the 
physicochemical properties of a compound. In the case of quercetin, 
pentacetylquercetin and 3-O-acetyl quercetin have been reported to show higher 
anti-inflammatory activity than that of the parent compound [3,13]. In this 
study, the anti-inflammatory activity and gastric ulcer property of other ester 
derivatives of quercetin were elaborated, i.e. TAQ as well as TPQ, in order to 
study the role of acyl substituents in anti-inflammatory and gastrointestinal 
toxicity.  
Acylation of quercetin by acid anhydride conducted at low or room temperature 
produces tetra substituted quercetin. The hydroxyl group at C5 is difficult to 
substitute because it forms intramolecular hydrogen bonding with the carbonyl 
group at C4 (Figure 3). A rise in temperature to 140°C is needed to obtain 
penta-substitution of quercetin esters when acid anhydride is used as acylating 
agent. Using acyl chloride, prolonging the reaction time to 48 hours produces 
penta substituted ester quercetin. 
 
Figure 4 Intramolecular hydrogen bonding (dashed line) of 
tetraacetylquercetin. 
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Carrageenan-induction of rat paw edema is a widely used method to determine 
anti-inflammatory activity. Inflammation induced by carrageenan is acute, non 
immune, well researched, and highly reproducible [14]. Guardia, et al. [4] have 
reported that intraperitonial administration of quercetin at a dose of 80 mg/kg 
gives 59% inhibition of edema volume in the carrageenan induced paw edema 
model. However, as shown in Figure 2, edema inhibition after oral 
administration of quercetin at a dose of 20 mg/kg bw was only below 20%. The 
lower dose and difference in administration route in our experiment influenced 
this discrepancy. This can be explained that when used orally, quercetin is 
metabolized so its level in systemic circulation is decreased. Both 
tetraacylquercetins enhanced the edema inhibiton, mainly at 1-3 hours. TAQ 
showed a marked increase of edema inhibiton compared to quercetin and TPQ. 
When used at a higher dose (equivalent to 80 mg/kgbw of quercetin), both TAQ 
and TPQ are predicted to show higher anti-inflammation activity due to the 
increase of free quercetin levels in systemic circulation. 
Cermak, et al. [15] have reported that after oral administration of quercetin, the 
conjugated quercetin was always detected as main metabolite, while very few 
free quercetin was detected in the blood. Quercetin is rapidly glucuronated, 
sulfated and methylated after diffusing into cytosol, resulting in very low levels 
of original compound found in the blood or plasma, mostly as metabolites.  
Biasutto, et al. [8] have reported that ester-based derivatives enhance 
bioavailability of quercetin. They studied the transepithelial absorption of 
several ester derivatives of quercetin across supported tight monolayers of 
MDCK-1, MDCK-2 and Caco-2 cells. Only a small percentage of quercetin was 
found in the basolateral compartement, on the other hand, quercetin sulfate was 
the primary metabolite detected on the basolateral side. Methylquercetin, 
methylquercetin sulfate and quercetin-O-quinone were the other compounds 
appearing on the basolateral side. In contrast, in the study of quercetin 
pentaacetate using MDCK cells there was no quercetin sulfate detected on the 
basolateral side. The quercetin pentaacetate partially deacetylated, so tetraacetyl 
quercetin, monoacetate quercetin and diacetate quercetin were detected on the 
basolateral side. Similar results were obtained with tetraacetyl quercetin 
derivatives. Acetylated forms (mainly of diacetyl quercetin and monoacetyl 
quercetin), but no parent or sulfated compounds, appeared on the basolateral 
side [8].  
Ester derivatives of quercetin may increase the systemic quercetin concentration 
and thus increase the anti-inflammatory activity. Biotransformation of quercetin 
may affect its pharmacological effect, including anti-inflammatory activity, 
because its metabolites are generally more hydrophilic and have negative charge 
at physiological pH [16]. Some in vitro studies have reported that quercetin-
mono-glucuronides possess antioxidant-scavenging activity, delay cell 
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membrane lipid peroxidation, as well as inhibit both cyclooxygenase and 
lipoxygenase expression and activity [17,18]. However, there is no report about 
the anti-inflammatory activities of methylated or sulfonated metabolites. It is 
suggested that acylation protects the hydroxyl group of quercetin from the 
methylation metabolism by cathecol-O-methyltransferase (COMT), sulfonation 
or glucuronidation, whereas methylated and sulfonated metabolites have no 
anti-inflammatory activity. In our experiment, a significant increase in activity 
only occurred at 1-3 hours. In vivo, these acylated species are predicted to be 
converted to quercetin by esterase. This causesa decrease of the effect due to the 
metabolism reaction of quercetin producing more hydrophylic metabolites that 
are easily excreted.  
The anti-inflammatory activity of TAQ was higher than that of TPQ. This is 
correlated to the increase in anti-inflammatory activity of acetylsalicylic acid 
(ASA) compared to that of salicylic acid. ASA irreversibly acetylates the OH 
group of serine at position 530 of cyclooxygenase-1 [19]. It was found that, 
although quercetin has a protective effect against NSAID induced-gastric ulcers, 
its tetraacetyl derivative caused gastric ulcers after 3 days of oral administration. 
This gastric ulcer-inducing effect is correlated to inhibition of cyclooxygenase-
1, which plays a role in gastrointestinal mucous biosynthesis. However, the 
gastric ulcer toxicity of TAQ was lower than that of diclofenac, which showed 
severe gastric ulcer toxicity due to the gastric ulcer protecting effect of 
quercetin [5].  
5 Conslusion 
It is concluded that tetraacyl derivatization enhances the oral anti-inflammatory 
activity of quercetin. The higher activity was shown by tetraacetyl derivatives. 
However, tetraacetylquercetin causes mild gastric ulcers, contrary to the gastric 
ulcer protection property of quercetin, while tetrapivaloylquercetin 
administration didnot cause gastric ulcers. 
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